Modulation of NMDA receptor at the synapse: Promising therapeutic interventions in disorders of the nervous system

European Journal of Pharmacology

Volumn 719, Issue 1-3, 2013, Pages 75-83

  Mellone, Manuela ^a   Gardoni, Fabrizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cell permeable peptides; Central nervous system disorders; N methyl D aspartate receptor; Post synaptic density; Preclinical studies; Trafficking

Indexed keywords

AMANTADINE; IFENPRODIL; IFENPRODIL DERIVATIVE; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PLACEBO; RECEPTOR SUBUNIT; TRAXOPRODIL; UNCLASSIFIED DRUG;

BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; DYSKINESIA; HUMAN; HUNTINGTON CHOREA; NEUROPATHIC PAIN; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE;

CELL-PERMEABLE PEPTIDES; CENTRAL NERVOUS SYSTEM DISORDERS; N-METHYL-D-ASPARTATE RECEPTOR; POST-SYNAPTIC DENSITY; PRECLINICAL STUDIES; TRAFFICKING;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; MOLECULAR TARGETED THERAPY; PROTEIN TRANSPORT; RECEPTORS, N-METHYL-D-ASPARTATE; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 84888304276     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.04.054     Document Type: Review

References (101)

1. M. Aarts, Y. Liu, L. Liu, S. Besshoh, M. Arundine, J.W. Gurd, Y.T. Wang, M.W. Salter, and M. Tymianski Treatment of ischemic brain damage by perfusing NMDA receptor-PSD-95 protein (Pubitemid 35231541)
2. J.T. Andreasen, A. Bach, M. Gynther, A. Nasser, J. Mogensen, K. Strømgaard, and D.S. Pickering UCCB01-125, a dimeric inhibitor of PSD-95, reduces inflammatory pain without disrupting cognitive or motor performance: comparison with the NMDA receptor antagonist MK-801 Neuropharmacol. 67C 2012 193 200
3. A. Bach, J.N. Eildal, N. Stuhr-Hansen, R. Deeskamp, M. Gottschalk, S.W. Pedersen, A.S. Kristensen, and K. Strømgaard Cell-permeable and plasma-stable peptidomimetic inhibitors of the postsynaptic density-95/N-methyl- D-aspartate receptor interaction J. Med. Chem. 54 2011 1333 1346
4. G.J. Bennett Update on the neurophysiology of pain transmission and modulation: focus on the NMDA receptor J. Pain Symptom Manage. 19 2000 S2 S6
5. S. Bialik, and A. Kimchi The death-associated protein kinases: structure, function, and beyond Ann. Rev. Biochem. 75 2006 189 210 (Pubitemid 44118031)
6. H.S. Chen, and S.A. Lipton The chemical biology of clinically tolerated NMDA receptor antagonists J. Neurochem. 97 2006 1611 1626 (Pubitemid 43873656)
7. K.S. Christopherson, B.J. Hillier, W.A. Lim, and D.S. Bredt PSD-95 assembles a ternary complex with N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain J. Biol. Chem. 274 1999 27467 27473
8. D.J. Cook, L. Teves, and M. Tymianski Treatment of stroke with a PSD-95 inhibitors in the gyrencephalic primate brain Nature 483 2012 213 217
9. D.J. Cook, L. Teves, and M. Tymianski A translational paradigm for the preclinical evaluation of the stroke neuroprotectant Tat-NR2B9c in gyrencephalic non human primates Sci. Transl. Med. 4 2012 (154ra133)
10. F.P. Da Silva-Junior, P. Braga-Neto, F. Sueli Monte, and V.M. de Bruin Amantadine reduces the duration of levodopa-induced dyskinesia: a randomized, double-blind, placebo-controlled study Parkinsonism Relat. Disord. 11 2005 449 452 (Pubitemid 41526996)
11. J. De Keyser, G. Sulter, and P.G. Luiten Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci. 22 1999 535 540
12. R. Dingledine, K. Borges, D. Bowie, and S.F. Traynelis The glutamate receptor ion channels Pharmacol. Rev. 51 1999 7 61 (Pubitemid 29113865)
13. R. D'Mello, F. Marchand, S. Pezet, S.B. McMahon, and A.H. Dickenson Perturbing PSD-95 interactions with NR2B-subtype receptors attenuates spinal nociceptive plasticity and neuropathic pain Mol. Ther. 19 2011 1780 1792
14. A.W. Dunah, Y. Wang, R.P. Yasuda, K. Kameyama, R.L. Huganir, B.B. Wolfe, and D.G. Standaert Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease Mol. Pharmacol. 57 2000 342 352 (Pubitemid 30084511)
15. B. Elahi, N. Phielipp, and R. Chen N-Methyl-D-aspartate antagonists in levodopa induced dyskinesia: a meta-analysis Can. J. Neurol. Sci. 39 2012 465 472
16. J. Fan, C.M. Cowan, L.Y. Zhang, M.R. Hayden, and L.A. Raymond Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington′s disease J. Neurosci. 29 2009 10928 10938
17. J. Fan, C.M. Gladding, L. Wang, L.Y. Zhang, A.M. Kaufman, A.J. Milnerwood, and L.A. Raymond P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease Neurobiol. Dis. 45 2012 999 1009
18. R.J. Ferrante, O.A. Andreassen, A. Dedeoglu, K.L. Ferrante, B.G. Jenkins, S.M. Hersch, and M.F. Beal Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington′s disease J. Neurosci. 22 2002 1592 1599 (Pubitemid 35386278)
19. S.K. Florio, C. Loh, S.M. Huang, A.E. Iwamaye, K.F. Kitto, K.W. Fowler, J.A. Treiberg, J.S. Hayflick, J.M. Walker, C.A. Fairbanks, and Y. Lai Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents Br. J. Pharmacol. 158 2009 494 506
20. F. Gardoni, B. Picconi, V. Ghiglieri, F. Polli, V. Bagetta, G. Bernardi, F. Cattabeni, M. Di Luca, and P. Calabresi A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia J. Neurosci. 26 2006 2914 2922
21. F. Gardoni, E. Marcello, and M. Di Luca PSD-MAGUK proteins and their role in central nervous system disorders Neuroscience 158 2009 324 333
22. F. Gardoni, V. Ghiglieri, M. Di Luca, and P. Calabresi Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson′s disease Prog. Brain Res. 183 2010 169 182
23. F. Gardoni, C. Sgobio, V. Pendolino, P. Calabresi, M. Di Luca, and B. Picconi Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias Neurobiol. Aging 33 2012 2138 21344
24. E.M. Garry, A. Moss, A. Delaney, F. O′Neill, J. Blakemore, J. Bowen, H. Husi, R. Mitchell, S.G. Grant, and S.M. Fleetwood-Walker Neuropathic sensitization of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice Curr. Biol. 13 2003 321 328 (Pubitemid 36230023)
25. J.R. Gingrich, K.A. Pelkey, S.R. Fam, Y. Huang, R.S. Petralia, R.J. Wenthold, and M.W. Salter Unique domain anchoring of Src to synaptic NMDA receptors via the mitochondrial protein NADH dehydrogenase subunit 2 Proc. Natl. Acad. Sci. USA 101 2004 6237 6242 (Pubitemid 38520558)
26. D.J. Gladstone, S.E. Black, and A.M. Hakim Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions Stroke 33 2002 2123 2136 (Pubitemid 34840080)
27. R.K. Graham, M.A. Pouladi, P. Joshi, G. Lu, Y. Deng, N.P. Wu, B.E. Figueroa, M. Metzler, V.M. André, E.J. Slow, L. Raymond, R. Friedlander, M.S. Levine, B.R. Leavitt, and M.R. Hayden Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease J. Neurosci. 29 2009 2193 2204
28. L. Groc, M. Heine, S.L. Cousins, F.A. Stephenson, B. Lounis, L. Cognet, and D. Choquet NMDA receptor surface mobility depends on NR2A-2B subunits Proc. Natl. Acad. Sci. USA 103 2006 18769 18774 (Pubitemid 44913485)
29. L. Groc, L. Bard, and D. Choquet Surface trafficking of N-methyl-D-aspartate receptors: physiological and pathological perspectives Neuroscience 158 2009 4 18
30. H. Guo, and L.Y. Huang Alteration in the voltage dependence of NMDA receptor channels in rat dorsal horn neurones following peripheral inflammation J. Physiol 537 2001 115 123 (Pubitemid 33076959)
31. A. Hadj Tahar, L. Gregoire, A. Darre, N. Belanger, L. Meltzer, and P.J. Bedard Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys Neurobiol. Dis. 15 2004 171 176 (Pubitemid 38296747)
32. P.J. Hallett, A.W. Dunah, P. Ravenscroft, S. Zhou, E. Bezard, A.R. Crossman, J.M. Brotchie, and D.G. Standaert Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTP-lesioned primate model of Parkinson′s disease Neuropharmacology 48 2005 503 516 (Pubitemid 40332408)
33. T.H. Hamza, H. Chen, E.M. Hill-Burns, S.L. Rhodes, J. Montimurro, D.M. Kay, A. Tenesa, V.I. Kusel, P. Sheehan, M. Eaaswarkhanth, D. Yearout, A. Samii, J.W. Roberts, P. Agarwal, Y. Bordelon, Y. Park, L. Wang, J. Gao, J.M. Vance, K.S. Kendler, S.A. Bacanu, W.K. Scott, B. Ritz, J. Nutt, S.A. Factor, C.P. Zabetian, and H. Payami Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson′s disease modifier gene via interaction with coffee PLoS Genet. 7 2011 e1002237
34. G.E. Hardingham, Y. Fukunaga, and H. Bading Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-oof and cell death pathways Nat. Neurosci. 5 2002 405 414 (Pubitemid 34454245)
35. G.E. Hardingham, and H. Bading Synaptic versus extrasynaptic NMDA receptor signaling: implications for neurodegenerative disorders Nat. Rev. Neurosci. 11 2010 682 696
36. M.Y. Heng, P.J. Detloff, P.L. Wang, J.Z. Tsien, and R.L. Albin In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease J. Neurosci. 29 2009 3200 3205
37. M.D. Hill, R.H. Martin, D. Mikulis, J.H. Wong, F.L. Silver, K.G. Terbrugge, G. Milot, W.M. Clark, R.L. McDonald, M.E. Kelly, M. Boulton, I. Fleetwood, C. McDougall, T. Gunnarsson, M. Chow, C. Lum, R. Dodd, J. Poublanc, T. Krings, A.M. Demchuk, M. Goval, R. Anderson, J. Bishop, G. Garman, and M. Tymianski Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomized, double-blind, placebo-controlled trial Lancet Neurol. 11 2012 942 950
38. M. Hollmann, and S. Heinemann Cloned glutamate receptors Annu. Rev. Neurosci. 17 1994 31 108 (Pubitemid 24117025)
39. D. Isaev, G. Gerber, S.K. Park, J.M. Chung, and M. Randik Facilitation of NMDA-induced currents and Ca2+ transients in the rat substantia gelatinosa neurons after ligation of L5-L6 spinal nerves Neuro. Rep. 11 2000 4055 4061 (Pubitemid 32038803)
40. B.R. Jarabek, R.P. Yasuda, and B.B. Wolfe Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington′s mouse model Brain 127 2004 505 516 (Pubitemid 38295468)
41. J. Kornhuber, J. Bormann, M. Hubers, K. Rusche, and P. Riederer Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor gated ion channel: a human postmortem brain study Eur. J. Pharmacol. 206 1991 297 300
42. M.B. Kennedy Signal-processing machines at the postsynaptic density Science 290 2000 750 754
43. T.W. Lai, W.C. Shyu, and Y.T. Wang Stroke intervention pathways: NMDA receptors and beyond Trends Mol. Med. 17 2011 266 275
44. C.G. Lau, and R.S. Zukin NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders Nat. Rev. Neurosci. 8 2007 413 426 (Pubitemid 46789232)
45. B.W. LeBlanc, M. Iwata, A.P. Mallon, C.N. Rupasinghe, D.J. Goebel, J. Marshall, M.R. Spaller, and C.Y. Saab A cyclic peptide targeted against PSD-95 blocks central sensitization and attenuates thermal hyperalgesia Neuroscience 167 2010 490 500
46. J.M. Lee, G.J. Zipfel, and D.W. Choi The changing landscape of ischemic brain injury mechanisms Nature 399 1999 A7 14
47. F. Léveillé, F. El Gaamouch, E. Gouix, M. Lecocq, D. Lobner, O. Nicole, and A. Buisson Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors FASEB J. 22 2008 4258 4271
48. M.S. Levine, C. Cepeda, and V.M. André Location, location, location: contrasting roles of synaptic and extrasynaptic NMDA receptors in Huntington′s disease Neuron 65 2010 145 147
49. J.H. Li, Y.H. Wang, B.B. Wolfe, K.E. Krueger, L. Corsi, G. Stocca, and S. Vicini Developmental changes in localization of NMDA receptor subunits in primary cultures of cortical neurons Eur. J. Neurosci. 10 1998 1704 1715 (Pubitemid 28327317)
50. L. Li, T.H. Murphy, M.R. Hayden, and L.A. Raymond Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington′s disease J. Neurophysiol. 92 2004 2738 2746 (Pubitemid 40340486)
51. X.J. Liu, J.R. Gingrich, M. Vargas-Caballero, Y.N. Dong, A. Sengar, S. Beggs, S.H. Wang, H.K. Ding, P.W. Frankland, and M.W. Salter Treatment of inflammatory and neuropathic pain by uncoupling Src from the NMDA receptor complex Nat. Med. 14 2008 1325 1332
52. P.A. Loschmann, C. De Groote, L. Smith, U. Wullner, G. Fischer, J.A. Kemp, P. Jenner, and T. Klockgether Antiparkinsonian activity of Ro 25-6981, a NR2B subunit specific NMDA receptor antagonist, in animal models of Parkinson′s disease Exp. Neurol. 187 2004 86 93 (Pubitemid 38470015)
53. E. Luginger, G.K. Wenning, S. Bosch, and W. Poewe Beneficial effects of amantadine on L-DOPA-induced dyskinesias in Parkinson′s disease Mov. Disord. 15 2000 873 878
54. R. Luthi-Carter, B.L. Apostol, A.W. Dunah, M.M. DeJohn, L.A. Farrell, G.P. Bates, A.B. Young, D.G. Standaert, L.M. Thompson, and J.H. Cha Complex alteration of NMDA receptors in transgenic Huntington′s disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation Neurobiol. Dis. 14 2003 624 636 (Pubitemid 37543539)
55. H. Monyer, N. Burnashev, D.J. Laurie, B. Sakmann, and P.H. Seeburg Developmental and regional expression in the rat brain and functional properties of four NMDA receptors Neuron 12 1994 529 540 (Pubitemid 24100885)
56. A.J. Milnerwood, C.M. Gladding, M.A. Pouladi, A.M. Kaufman, R.M. Hines, J.D. Boyd, R.W. Ko, O.C. Vasuta, R.K. Graham, M.R. Hayden, T.H. Murphy, and L.A. Raymond Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington′s disease mice Neuron 65 2010 178 190
57. M. Morissette, M. Dridi, F. Calon, A. Hadj Tahar, L.T. Meltzer, P.J. Bedard, and T. Di Paolo Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors Synapse 60 2006 239 250 (Pubitemid 44036718)
58. G.F. Morris, R. Bullock, S.B. Marshall, A. Marmarou, A. Maas, and L.F. Marshall Failure of competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two phase III clinical trials. The Selfotel Investigators J. Neurosurg. 91 1999 737 743 (Pubitemid 30053144)
59. J.E. Nash, S.H. Fox, B. Henry, M.P. Hill, D. Peggs, S. McGuire, Y. Maneuf, C. Hille, J.M. Brotchie, and A.R. Crossman Antiparkinsonian actions of ifenprodil in the MPTP-lesioned marmoset model of Parkinson′s disease Exp. Neurol. 165 2000 136 142
60. J.E. Nash, P. Ravenscroft, S. McGuire, A.R. Crossman, F.S. Menniti, and J.M. Brotchie The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTPlesioned marmoset model of Parkinson′s disease Exp. Neurol. 188 2004 471 479 (Pubitemid 38891607)
61. J.E. Nash, T.H. Johnston, G.L. Collingridge, C.C. Garner, and J.M. Brotchie Subcellular redistribution of the synapse-associated proteins PSD-95 and SAP97 in animal models of Parkinson′s disease and L-DOPA-induced dyskinesia FASEB J. 19 2005 583 585 (Pubitemid 40471251)
62. C. Nozaki, A.M. Vergnano, D. Filliol, A.M. Ouagazzal, A. Le Goff, S. Carvalho, D. Reiss, C. Gaveriaux-Ruff, J. Neyton, P. Paoletti, and B.L. Kieffer Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit Nat. Neurosci. 14 2011 1017 1022
63. J.G. Nutt, S.A. Gunzler, T. Kirchhoff, P. Hogarth, J.L. Weaver, M. Krams, B. Jamerson, F.S. Menniti, and J.W. Landen Effects of a NR2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism Mov. Disord. 23 2008 1860 1866
64. S. Okamoto, M.A. Pouladi, M. Talantova, D. Yao, P. Xia, D.E. Ehrnhoefer, R. Zaidi, A. Clemente, M. Kaul, R.K. Graham, D. Zhang, H.S. Vincent Chen, G. Tong, M.R. Hayden, and S.A. Lipton Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin Nat. Med. 15 2009 1407 1413
65. A.B. Petrenko, T. Yamakura, H. Baba, and K. Shimoji The role of N-Methyl-D-Aspartate (NMDA) receptors in pain: a review Anesth. Analg. 97 2003 1108 1116 (Pubitemid 37158698)
66. B. Picconi, D. Centonze, K. Hakansson, G. Bernardi, P. Greengard, G. Fisone, M.A. Cenci, and P. Calabresi Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia Nat. Neurosci. 6 2003 501 506 (Pubitemid 36514698)
67. B. Picconi, F. Gardoni, D. Centonze, D. Mauceri, M.A. Cenci, G. Bernardi, P. Calabresi, and M. Di Luca Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism J. Neurosci. 24 2004 5283 5291 (Pubitemid 38747668)
68. G. Porras, A. Berthet, B. Dehay, Q. Li, L. Ladepeche, E. Normand, S. Dovero, A. Martinez, E. Doudnikoff, M.L. Martin-Négrier, Q. Chuan, B. Bloch, D. Choquet, E. Boué-Grabot, L. Groc, and E. Bezard PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking J. Clin. Invest. 122 2012 3977 3989
69. D. Rylander, A. Recchia, F. Mela, A. Dekundy, W. Danysz, and M.A. Cenci Pharmacological modulation of glutamate transmission in a rat model of L-DOPA-induced dyskinesia: effects on motor behavior and striatal nuclear signaling J. Pharmacol. Exp. Ther. 330 2009 227 235
70. A. Sanz-Clemente, R.A. Nicoll, and K.W. Roche Diversity in NMDA receptor composition: many regulators, many consequences Neuroscientist 19 2013 62 75
71. R. Sattler, Z. Xiong, W.Y. Lu, M. Halfner, J.F. MacDonald, and M. Tymianski Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein Science 284 1999 1845 1848
72. V. Sgambato-Faure, and M.A. Cenci Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson′s disease Prog. Neurobiol. 96 2012 69 86
73. M. Sheng, J. Cummings, L.A. Roldan, Y.N. Jan, and L.Y. Jan Changing subunit composition of heteromeric NMDA receptors during development of rat cortex Nature 368 1994 144 147 (Pubitemid 24101524)
74. B.J. Snow, L. Macdonald, D. McAuley, and W. Wallis The effect of amantadine on levodopa-induced dyskinesias in Parkinson′s disease: a double-blind, placebo controlled study Clin. Neuropharmacol. 23 2000 82 85 (Pubitemid 30212217)
75. E.C. Stack, A. Dedeoglu, K.M. Smith, K. Cormier, J.K. Kubilus, M. Bogdanov, W.R. Matson, L. Yang, B.G. Jenkins, R. Luthi-Carter, N.W. Kowall, S.M. Hersch, M.F. Beal, and R.J. Ferrante Neuroprotective effects of synaptic modulation in Huntington′s disease R6/2 mice J. Neurosci. 27 2007 12908 12915 (Pubitemid 350159593)
76. K. Steece-Collier, L.K. Chambers, S.S. Jaw-Tsai, F.S. Menniti, and J.T. Greenamyre Antiparkinsonian actions of CP101,606, an antagonist of NR2B subunit-containing N-methyl-D-aspartate receptors Exp. Neurol. 163 2000 239 243 (Pubitemid 30314379)
77. H.-S. Sun, T.A. Doucette, Y. Liu, Y. Fang, L. Teves, M. Aarts, C.L. Ryan, P.B. Bernard, A. Lau, J.P. Forder, M.W. Salter, Y.T. Wang, R.A. Tasker, and M. Tymianski Effectivness of PSD95 inhibitors in permanent and transient focal ischemia in the rat Stroke 39 2008 2544 2553
78. Y. Sun, A. Savanenin, P.H. Reddy, and Y.F. Liu Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95 J. Biol. Chem. 276 2001 24713 24718
79. C. Taghibiglou, H.G. Martin, T.W. Lai, T. Cho, S. Prasad, L. Kojic, J. Lu, Y. Liu, E. Lo, S. Zhang, J.Z. Wu, Y.P. Li, Y.H. Wen, J.H. Imm, M.S. Cynader, and Y.T. Wang Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries Nat. Med. 15 2009 1399 1406
80. S.J. Tallaksen-Greene, A. Janiszewska, K. Benton, L. Ruprecht, and R.L. Albin Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease Exp. Neurol. 225 2010 402 407
81. F. Tao, Y.X. Tao, J.A. Gonzalez, M. Fang, P. Mao, and R.A. Johns Knockdown of PSD-95/SAP90 delays the development of neuropathic pain in rats Neuroreport 12 2001 3251 3255 (Pubitemid 33010653)
82. F. Tao, Y.X. Tao, P. Mao, and R.A. Johns Role of postsynaptic density protein-95 in the maintenance of peripheral nerve injury-induced neuropathic pain in rats Neuroscience 117 2003 731 739 (Pubitemid 36263166)
83. F. Tao, Q. Su, and R.A. Johns Cell-permeable peptide Tat-PSD-95 PDZ2 inhibits chronic inflammatory pain behaviors in mice Mol. Ther. 16 2008 1776 1782
84. Y.X. Tao, Y.Z. Huang, L. Mei, and R.A. Johns Expression of PSD-95/SAP90 is critical for N-methyl-D-aspartate receptor-mediated thermal hyperalgesia in the spinal cord Neuroscience 98 2000 201 206 (Pubitemid 30347281)
85. Y.X. Tao, and S.N. Raja Are synaptic MAGUK proteins involved in chronic pain? Trends Pharmacol. Sci. 25 2004 397 400 (Pubitemid 38981553)
86. Y. Terasaki, T. Sasaki, Y. Yagita, S. Okazaki, Y. Sugiyama, N. Oyama, E. Omura-Matsuoka, S. Sakoda, and K. Kitagawa Activation of NR2A receptors induces ischemic tolerance through CREB signaling J. Cereb. Blood Flow Metab. 2010 1441 1449
87. A. Thomas, D. Iacono, A.L. Luciano, K. Armellino, A. Di Iorio, and M. Onofrj Duration of amantadine benefit on dyskinesia of severe Parkinson′s disease J. Neurol. Neurosurg. Psych. 75 2004 141 143 (Pubitemid 38091285)
88. H. Tochio, Y.K. Mok, Q. Zhang, H.M. Kan, D.S. Bredt, and M. Zhang Formation of nNOS/PSD95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain J. Mol. Biol. 2303 2000 359 370
89. K.R. Tovar, and G.L. Westbrook The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro J. Neurosci. 19 1999 4180 4188 (Pubitemid 29222289)
90. S.F. Traynelis, L.P. Wollmuth, C.J. McBain, F.S. Menniti, K.M. Vance, K.K. Ogden, K.B. Hansen, H. Yuan, S.J. Myers, and R. Dingledine Glutamate receptor ion channels: structure, regulation, and function Pharmacol. Rev. 62 2010 405 496
91. W. Tu, X. Xu, L. Peng, X. Zhong, W. Zhang, N.M. Soundarapandian, C. Balel, M. Wang, N. Jia, W. Zhang, F. Lew, S.L. Chan, Y. Chen, and Y. Lu DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke Cell 140 2010 222 234
92. L. Verhagen Metman, P. Del Dotto, P. van den Munckhof, J. Fang, M.M. Mouradian, and T.N. Chase Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson′s disease Neurology 50 1998 1323 1326 (Pubitemid 28240346)
93. R.H. Wessell, S.M. Ahmed, F.S. Menniti, G.L. Dunbar, T.N. Chase, and J.D. Oh NR2B selective NMDA receptor antagonist CP-101,606 prevents levodopa-induced motor response alterations in hemi-parkinsonian rats Neuropharmacology 47 2004 184 194 (Pubitemid 38824642)
94. E. Wolf, K. Seppi, R. Katzenschlager, G. Hochschorner, G. Ransmayr, P. Schwingenschuh, E. Ott, I. Kloiber, D. Haubenberger, E. Auff, and W. Poewe Long-term antidyskinetic efficacy of amantadine in Parkinson′s disease Mov. Disord. 25 2010 1357 1363
95. P.L. Wood, and J.E. Hawkinson N-methyl-D-aspartate antagonists for stroke and head trauma Expert Opin. Investig. Drugs 6 1997 389 397 (Pubitemid 27186388)
96. C.J. Woolf, and M.W. Salter Neuronal plasticity increasing the gain in pain Science 288 2000 1765 1769
97. J. Xu, P. Kurup, Y. Zhang, S.M. Goebel-Goody, P.H. Wu, A.H. Hawasli, M.L. Baum, J.A. Bibb, and P.J. Lombroso Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP J. Neurosci. 29 2009 9330 9343
98. M.M. Zeron, H.B. Fernandes, C. Krebs, J. Shehadeh, C.L. Wellington, B.R. Leavitt, K.G. Baimbridge, M.R. Hayden, and L.A. Raymond Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington′s disease Mol. Cell. Neurosci. 25 2004 469 479 (Pubitemid 38366412)
99. J. Zhang, T.X. Xu, P.J. Hallett, M. Watanabe, S.G. Grant, O. Isacson, and W.D. Yao PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex J. Neurosci. 29 2009 2948 2960
100. S.J. Zhang, M.N. Steijaert, D. Lau, G. Schütz, and C. Delucinge-Vivier Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death Neuron 53 2007 549 562 (Pubitemid 46216756)
101. L. Zhou, F. Li, H.B. Xu, C.X. Luo, H.Y. Wu, M.M. Zhu, W. Lu, X. Ji, Q.G. Zhou, and D.Y. Zhu Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95 Nat. Med 16 2010 1439 1443